References Bowers et al (1992), The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short-statured children after oral administration
The study of 333,687 veterans compared 132,551 participants who were prescribed GLP-1s for their type 2 diabetes with 201,136 participants who were prescribed sulfonylureas, another treatment for diabetes, and followed the patients outcomes for up to three years
Early clinical studies are promising, but long-term safety, availability, and approval status still matter
This hormone is primarily found in the intestines
It is a medically supervised protocol that works when it is paired with good sleep, training, and nutrition
[1] However, the FDA does require blood collection establishments to maintain comprehensive donor eligibility criteria that protect both donors and recipients